The molecular characterization of gastric cancers has revealed that PI3K/AKT/mTOR pathway abnormalities are associated with a high recurrence rate of gastric cancer, suggesting that these molecules are potential therapeutic targets (2014). This evidence concerns the gene MTOR and gastric cancer.